ALLIANCEBERNSTEIN L.P. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$636,547
-9.7%
50,0430.0%0.00%
Q2 2023$704,605
-8.9%
50,0430.0%0.00%
Q1 2023$773,164
-5.7%
50,0430.0%0.00%
Q4 2022$820,205
-11.4%
50,0430.0%0.00%
Q3 2022$926,000
+41.6%
50,043
+0.7%
0.00%
Q2 2022$654,000
+41.9%
49,7000.0%0.00%
Q1 2022$461,000
-14.5%
49,700
-10.0%
0.00%
Q4 2021$539,000
-71.3%
55,2000.0%0.00%
-100.0%
Q3 2021$1,876,000
-7.2%
55,2000.0%0.00%0.0%
Q2 2021$2,021,000
-97.7%
55,200
-97.2%
0.00%
-97.4%
Q1 2021$89,353,000
+4.0%
1,992,706
+32.4%
0.04%
-4.9%
Q4 2020$85,905,000
+8.4%
1,505,261
-2.6%
0.04%
-4.7%
Q3 2020$79,250,000
-1.9%
1,544,836
+14.2%
0.04%
-8.5%
Q2 2020$80,806,000
+55.5%
1,353,077
+7.2%
0.05%
+27.0%
Q1 2020$51,977,000
-33.6%
1,262,497
+0.4%
0.04%
-15.9%
Q4 2019$78,280,000
+71.5%
1,257,711
-6.5%
0.04%
+57.1%
Q3 2019$45,650,000
+7650.4%
1,345,024
+5053.3%
0.03%
Q2 2019$589,000
-95.1%
26,100
-95.0%
0.00%
-100.0%
Q1 2019$12,136,000
-6.6%
522,881
-15.6%
0.01%
-20.0%
Q4 2018$12,999,000
-42.6%
619,318
+6.0%
0.01%
-33.3%
Q3 2018$22,629,000
+20.9%
584,417
+22.9%
0.02%
+15.4%
Q2 2018$18,713,000
+3200.4%
475,546
+1802.2%
0.01%
Q4 2017$567,00025,0000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,086,723$85,910,00025.70%
SV Health Investors, LLC 449,951$18,525,00015.54%
Redmile Group, LLC 5,116,263$210,637,0005.90%
Eversept Partners, LP 414,081$17,047,7154.24%
Sunesis Advisors, LLC 96,299$3,965,0003.99%
Avoro Capital Advisors LLC 2,000,000$82,340,0002.78%
Opaleye Management Inc. 222,000$9,140,0002.42%
SECTORAL ASSET MANAGEMENT INC 204,059$8,401,0001.61%
Artal Group S.A. 800,000$32,936,0001.39%
Atika Capital Management LLC 141,000$5,805,0001.11%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders